Crescent Biopharma, Inc.$12.27 %
Analyst Rating: Hold
Stock Details
CEO
Joshua T. Brumm
Sector
Healthcare
Industry
Biotechnology
Full Time Employees
33
Address
300 5th Avenue, Waltham, MA, 02451
Crescent Biopharma, Inc., an oncology company, develops therapies for cancer patients. Its pipeline includes a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates to treat solid tumors. The company is headquartered in Waltham, Massachusetts.
Top Competitors
Income Statement
Financials
Selected Year